Companies/JP/4570

IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. · 株式会社免疫生物研究所

Income flow

Annual
4570 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Immunity RelatedJPY 1BCosmeticsJPY 3MRevenueJPY 1B+4% Y/YGross profitJPY 707M+11% Y/YCost of revenueJPY 298MOperating profitJPY 281M+34% Y/YOperating expensesJPY 426MNet profitJPY 329M+32% Y/YSG&AJPY 426M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 1.0B
  • Immunity RelatedJPY 1.0B99.7%
  • CosmeticsJPY 3M0.3%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.70%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).6PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.15.2%Shares outTotal shares currently outstanding (issued and not retired).9.3MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).7.7M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
7.5 · 2027-03-30
Stock splits
  1. 10:12013-09-26